Cargando…

Is there a rationale for perioperative nutrition therapy in the times of ERAS?

In order to increase patient compliance in Enhanced Recovery after Surgery (ERAS) programs, assessment and monitoring of functional and nutritional status should be routinely performed. Sarcopenic obesity is frequently underestimated and has been shown to be a significant risk factor for the develop...

Descripción completa

Detalles Bibliográficos
Autor principal: Weimann, Arved
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059352/
https://www.ncbi.nlm.nih.gov/pubmed/33977125
http://dx.doi.org/10.1515/iss-2019-0012
_version_ 1783681181977411584
author Weimann, Arved
author_facet Weimann, Arved
author_sort Weimann, Arved
collection PubMed
description In order to increase patient compliance in Enhanced Recovery after Surgery (ERAS) programs, assessment and monitoring of functional and nutritional status should be routinely performed. Sarcopenic obesity is frequently underestimated and has been shown to be a significant risk factor for the development of postoperative complications. With special regard to gastrointestinal cancer patients undergoing neoadjuvant treatment, nutritional deficiencies may develop stepwise and increase during therapy. In the case of proven deficits, recent strategies including “prehabilitation” focus on making the patient fit for an ERAS program. Evidence-based guidelines for perioperative nutrition therapy have been available.
format Online
Article
Text
id pubmed-8059352
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-80593522021-05-10 Is there a rationale for perioperative nutrition therapy in the times of ERAS? Weimann, Arved Innov Surg Sci Review In order to increase patient compliance in Enhanced Recovery after Surgery (ERAS) programs, assessment and monitoring of functional and nutritional status should be routinely performed. Sarcopenic obesity is frequently underestimated and has been shown to be a significant risk factor for the development of postoperative complications. With special regard to gastrointestinal cancer patients undergoing neoadjuvant treatment, nutritional deficiencies may develop stepwise and increase during therapy. In the case of proven deficits, recent strategies including “prehabilitation” focus on making the patient fit for an ERAS program. Evidence-based guidelines for perioperative nutrition therapy have been available. De Gruyter 2019-11-30 /pmc/articles/PMC8059352/ /pubmed/33977125 http://dx.doi.org/10.1515/iss-2019-0012 Text en ©2019 Weimann A., published by De Gruyter, Berlin/Boston https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 Public License.
spellingShingle Review
Weimann, Arved
Is there a rationale for perioperative nutrition therapy in the times of ERAS?
title Is there a rationale for perioperative nutrition therapy in the times of ERAS?
title_full Is there a rationale for perioperative nutrition therapy in the times of ERAS?
title_fullStr Is there a rationale for perioperative nutrition therapy in the times of ERAS?
title_full_unstemmed Is there a rationale for perioperative nutrition therapy in the times of ERAS?
title_short Is there a rationale for perioperative nutrition therapy in the times of ERAS?
title_sort is there a rationale for perioperative nutrition therapy in the times of eras?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059352/
https://www.ncbi.nlm.nih.gov/pubmed/33977125
http://dx.doi.org/10.1515/iss-2019-0012
work_keys_str_mv AT weimannarved istherearationaleforperioperativenutritiontherapyinthetimesoferas